GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (OTCPK:ZLDAF) » Definitions » Payments of Debt

ZLDAF (Zelira Therapeutics) Payments of Debt : $0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Zelira Therapeutics Payments of Debt?

Zelira Therapeutics's Payments of Debt for the six months ended in Jun. 2024 was $0.00 Mil.

Zelira Therapeutics's Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.


Zelira Therapeutics Payments of Debt Historical Data

The historical data trend for Zelira Therapeutics's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelira Therapeutics Payments of Debt Chart

Zelira Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zelira Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Zelira Therapeutics Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zelira Therapeutics Payments of Debt Related Terms

Thank you for viewing the detailed overview of Zelira Therapeutics's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Zelira Therapeutics Business Description

Traded in Other Exchanges
Address
101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.